Delivery Order SPE2DB24D1205-SPE2DB25FCYFF
- Not listed
- The Defense Logistics Agency (DLA) awarded a $1,360.45 delivery order to AmerisourceBergen Drug Corp for Mounjaro 10 mg/0.5 mL pens on July 22, 2025, with completion expected by July 23, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a single delivery order fulfilling pharmaceutical supply needs for federal medical procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for...
- The Defense Logistics Agency awarded a $2,955.49 firm fixed price delivery order to AmerisourceBergen Drug Corp for supply of Mounjaro 7.5 mg/0.5 mL pens on July 15, 2025, with completion targeted for July 16, 2025. This non-set-aside delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The product will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $54,083.66 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 mL pens on September 12, 2025. This firm fixed-price delivery order, which is non-set-aside and competitively awarded, is scheduled for completion by September 15, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $4,760.40 to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 ml pens on September 18, 2025, with completion scheduled for September 19, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive procurement for pharmaceutical supplies to support federal medical needs. The award was made to AmerisourceBergen's corporate office, with performance occurring at the company's...
- The Defense Logistics Agency awarded a delivery order valued at $2,586.22 to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Mounjaro 5 mg/0.5 mL pens (0.5 mL). This firm fixed-price delivery order is non-competitive and utilizes a competitively awarded indefinite delivery contract vehicle. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 25, 2025. As a major...
- The Defense Logistics Agency (DLA) awarded a $1,632.54 delivery order contract to AmerisourceBergen Drug Corp on June 3, 2025, for the supply of Mounjaro 10 mg/0.5 mL pens. This firm fixed-price delivery order, with an ultimate completion date of June 4, 2025, will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting the contractor's capability to meet federal pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,843.65 to AmerisourceBergen Drug Corp for Mounjaro 5 mg/0.5 ml pens on September 16, 2025, with completion scheduled for September 17, 2025. This delivery order represents a firm fixed price procurement issued under a non-set-aside competitive acquisition. The award was placed to AmerisourceBergen Drug Corp's corporate office located in Conshohocken, Pennsylvania, reflecting the company's role as a critical pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $5,843.43 to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 mL pens on September 3, 2025, with completion scheduled for September 4, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award under open procurement. The product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate office, which serves as a major...
- The Defense Logistics Agency (DLA) awarded a $10,843.58 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Mounjaro 15 mg/0.5 ml pen injections on June 20, 2025, with a completion date of June 23, 2025. This non-set-aside contract represents a routine pharmaceutical supply order fulfilling military healthcare needs through the federal medical procurement system. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving...
- The Defense Logistics Agency awarded a $9,795.24 delivery order to AmerisourceBergen Drug Corp for Mounjaro 15 mg/0.5 ml pen units on September 11, 2025, with completion scheduled for September 12, 2025. This firm fixed-price contract represents a non-set-aside competitive award for pharmaceutical supply to support federal healthcare needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for military and veteran healthcare systems through its...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FCYFFDelivery Order
The Defense Logistics Agency (DLA) awarded a $10,538.63 firm fixed price delivery order to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 mL pens on July 2, 2025, with completion scheduled for July 3, 2025. This non-set-aside award represents a routine pharmaceutical procurement to support federal medical supply needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for military and veteran healthcare systems through its extensive federal contract portfolio. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. Through this contract structure, AmerisourceBergen Drug Corp continues to serve the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems with flexible and scalable medical procurement capabilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.5k | 7/2/25 |